Matinas BioPharma announces pricing of public offering of common stock
Matinas BioPharma announced pricing of its underwritten registered public offering of 27,272,727 shares of its common stock, offered at a price to the public of $1.10 per share for gross proceeds of $30.0 million. Matinas granted underwriters a 30-day option to purchase up to 4,090,909 shares. March 15, 2019